# Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine

> **NCT05804396** · NA · WITHDRAWN · sponsor: **Neurolief Ltd.**

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Relivion®

## Key facts

- **NCT ID:** NCT05804396
- **Lead sponsor:** Neurolief Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-11-24
- **Primary completion:** 2024-11-24
- **Final completion:** 2024-11-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05804396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05804396, "Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05804396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*